维普中文期刊产品整合服务
25篇 您的检索式:作者名="Chillar"
    题名 作者 年代 出处 被引量
1Laparoscopic sleeve gastrectomy:More than a restrictive bariatric surgery procedure?显示文摘Sleeve gastrectomy(SG) is a restrictive bariatric surgery technique that was first used as part of restrictive horizontal gastrectomy in the original Scopinaro type biliopancreatic diversion. Its good results as a single technique have led to a rise in its use, and it is currently the second most performed technique worldwide. SG achieves clearly better results than other restrictive techniques and is comparable in some aspects to the Roux-en-Y gastric bypass, the current gold standard in bariatric surgery. These benefits have been associated with different pathophysiologic mechanisms unrelated to weight loss such as increased gastric emptying and intestinal transit, and activation of hormonal mechanisms such as increased GLP-1 hormone and decreased ghrelin. The aim of this review was to highlight the salient aspects of SG regarding its historical evolution, pathophysiologic mechanisms, main results, clinical applications and perioperative complications.David Benaiges Antonio Más-Lorenzo Albert Goday José M Ramon Juan J Chillarón Juan Pedro-Botet Juana A Flores-Le Roux 2015World Journal of Gastroenterology2015,21,41:6
2外科减肥手术后高血压缓解和复发的预测因素显示文摘目前,只有很少量研究涉及外科减肥手术后高血压得到缓解和复发的影响因素,没有可用于预测高血压复发相关因素的信息。该研究的目的是评估在外科减肥手术后第1年和第3年里高血压的缓解情况和复发率,并寻找可能的预测因素。Benaiges D Sagué M Flores-Le Roux JA Pedro-Botet J Ramón JM Villatoro M Chillarón JJ Pera M Más A Grande L Goday A 陈云 2016中华高血压杂志2016,24,9:2
3Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women withbreast cancer显示文摘Wu Y Mohamed H Chillar R 0,,01:1
4Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer显示文摘Wu Y Mohamed H Chillar R 2008Breast Cancer Res2008,10,1:1
5Mammary hamartoma显示文摘Ruiz Tovar J Reguero Callejas ME A1áez Chillarón AB 0,,:1
6The light subunit of system bo, + is fully functional in the absence of the heavy subunit 显示文摘REIG N CHILLAR N J BARTOCCIONI P 2002The EMBO Journal2002,21,:1
7Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship 显示文摘Ather S Chan W Chillar A 2011Am Heart J2011,161,3:1
8Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship显示文摘Sameer Ather Wenyaw Chan Annirudha Chillar David Aguilar Allison M. Pritchett Kumudha Ramasubbu Xander H.T. Wehrens Anita Deswal Biykem Bozkurt 2011American Heart Journal2011,,3:1
9Reboxetine anovel a ntidepressant 显示文摘KADHE NG CHILLAR AJ DESHMUKH YA 2003J Postgrad Med2003,49,4:1
10Reboxetine:an-ovel antidepressant显示文摘 Chillar AJ Deshmukh YA 2003J Postgard Med2003,49,4:1
11Reboxetine: a novel antidepressant 显示文摘KADHE NG CHILLAR AJ DESHMUKH YA 2003J Postgard Med2003,49,4:1
12Reboxetine: a novel antidepressant 显示文摘Kadhe N G Chillar A J Deshmukh Y A 2003J Postgrad Med2003,49,:1
13Type 1 diabetes, metabolic syndrome and cardiovascular risk显示文摘Juan J. Chillarón Juana A. Flores Le-Roux David Benaiges Juan Pedro-Botet 2013Metabolism2013,,:1
14Efficacy of treatment for hyperglycemic crisis in elderly diabetic patients in a day hospital显示文摘Benaiges D Chillarón JJ Carrera MJ 2014Clin Interv Aging2014,9,:1
15Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment显示文摘Wu YY Saldana L Chillar R 2002Int J Oncol2002,20,3:1
16Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction:a complex relationship显示文摘Ather S Chan W Chillar A 2011Am Heart J2011,161,3:1
17Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment显示文摘Wu Y Saldana L Chillar R 2002Int J Oncol2002,20,3:1
18Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen显示文摘The prevalence of type 2 diabetes mellitus(T2DM) has risen in recent decades, and cardiovascular disease remains the leading cause of death in this population. Several clinical trials have demonstrated the benefit of tight control of risk factors on the incidence and mortality of cardiovascular disease. However, in clinical practice, few patients achieve the therapeutic goals. The current diagnostic procedures for subclinical cardiovascular disease in T2 DM patients have not been shown to improve prognosis or mortality, probably because they do not categorize cardiovascular risk. Thus, clinical practice guidelines do not systematically recommend screening for subclinical atherosclerosis in these patients, although it is known that patients with extracoronary atherosclerosis, microangiopathy and poorlycontrolled cardiovascular risk factors are at high risk for cardiovascular disease. Improvements in the reliability of diagnostic tests, with fewer side effects and better cost efficiency, may better help to stratify cardiovascular risk in this group of patients, and further evaluation on this topic should be considered.Juan J Chillarón Juana A Flores-Le Roux David Benaiges Juan Pedro-Botet 2014World Journal of Clinical Cases2014,2,9:1
19Clinical significance of Akt and HER2/neu overexpression in AricanAmerican and Latina women with breast cancer显示文摘Wu Y Mohamed H Chillar R Ali I 2008Breast 1 Cancer Res2008,10,1:1
20High power optically pumped semiconductor lasers 显示文摘Chillar J Butterworth S Zeitschel A 2004SPIE2004,5332,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费